Scholarlink

<p>Effective mucosal vaccines are critical for controlling infectious diseases in poultry, yet limitations in antigen delivery systems hinder their development. Here, we present a transgenic <i>Eimeria tenella</i> platform engineered to express multicopy viral capsid protein 1 (VP1) and viral capsid protein 2 (VP2) antigens of chicken infectious anemia virus (CIAV), a major immunosuppressive pathogen in poultry. Using a quadripartite co-transfection system driven by high-activity promoters, we achieved stable integration and expression of heterologous antigens, confirmed via PCR and Western blotting. Fluorescence-assisted cell sorting increased the proportion of recombinant parasites to &gt;90%. Despite modestly reduced fecundity, the engineered strain (Et-TetVP1VP2) retained immunogenicity and induced robust humoral and cellular immune responses in vivo. Oral immunization of chickens conferred protection, reducing viral load and pathological lesions upon CIAV challenge. This work establishes <i>E. tenella</i> as a promising oral vaccine vector, offering a scalable and cost-effective platform for antigen delivery against avian pathogens, with broader implications for mucosal vaccine design.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

An oral Eimeria-vectored vaccine induces protective immunity against chicken infectious anemia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月5日

查看全文
  • Yanzhen Liao,
  • Lei Wang,
  • Yubo Shi,
  • Lin Liang,
  • Ruiying Liang,
  • Jiabo Ding,
  • Xingju Song,
  • Xinming Tang

摘要

Effective mucosal vaccines are critical for controlling infectious diseases in poultry, yet limitations in antigen delivery systems hinder their development. Here, we present a transgenic Eimeria tenella platform engineered to express multicopy viral capsid protein 1 (VP1) and viral capsid protein 2 (VP2) antigens of chicken infectious anemia virus (CIAV), a major immunosuppressive pathogen in poultry. Using a quadripartite co-transfection system driven by high-activity promoters, we achieved stable integration and expression of heterologous antigens, confirmed via PCR and Western blotting. Fluorescence-assisted cell sorting increased the proportion of recombinant parasites to >90%. Despite modestly reduced fecundity, the engineered strain (Et-TetVP1VP2) retained immunogenicity and induced robust humoral and cellular immune responses in vivo. Oral immunization of chickens conferred protection, reducing viral load and pathological lesions upon CIAV challenge. This work establishes E. tenella as a promising oral vaccine vector, offering a scalable and cost-effective platform for antigen delivery against avian pathogens, with broader implications for mucosal vaccine design.